Personalized nutrition guided by continuous glucose monitors for type 2 diabetes
Personalized Nutrition Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus
['FUNDING_R01'] · UNIVERSITY OF MINNESOTA · NIH-11240325
See whether using continuous glucose monitors to tailor meals helps adults with type 2 diabetes keep blood sugar under better control.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11240325 on ClinicalTrials.gov |
What this research studies
You would wear a continuous glucose monitor (CGM) and either receive personalized medical nutrition therapy based on your real-time glucose patterns or not, depending on the group you are randomized into. The 12-week trial enrolls 72 adults with type 2 diabetes and baseline A1c between 6.8% and 8.5%, split into four groups combining blinded or unblinded CGM with or without nutrition counseling. Study staff will review CGM data to provide individualized meal guidance for those in the nutrition therapy arms, while others will wear CGMs without tailored counseling. The team will compare changes in A1c, glucose variability, and diabetes self-efficacy across the groups.
Who could benefit from this research
Good fit: Adults (21+) with type 2 diabetes and a baseline hemoglobin A1c of about 6.8–8.5% who are willing to wear a CGM and attend nutrition counseling sessions are ideal candidates.
Not a fit: People with type 1 diabetes, those with A1c outside the study range, pregnant individuals, or anyone unwilling/unable to use a CGM or attend visits are unlikely to benefit from or qualify for this trial.
Why it matters
Potential benefit: If successful, this approach could improve blood sugar control, reduce glucose swings, and help people feel more confident managing their diabetes through personalized meal plans.
How similar studies have performed: Previous studies show CGM use in lifestyle programs can lower A1c and improve diabetes self-efficacy, but using CGM data specifically to personalize medical nutrition therapy is a relatively new approach with limited large trial evidence.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BANTLE, ANNE E — UNIVERSITY OF MINNESOTA
- Study coordinator: BANTLE, ANNE E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus